Cure My Disease

Don't miss your cure!

 Log in / Sign up

Community ear health workers may curb hearing loss in aboriginal kids

NCT ID NCT03916029

Disease control Sponsor: Menzies School of Health Research Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

This trial tests whether training and employing local community members as ear health facilitators can improve ear care for Aboriginal and Torres Strait Islander children in the Northern Territory. The facilitators would help with ear assessments and management of otitis media, a common middle ear infection that can cause hearing loss. The study compares this approach to current practice, looking at how many children get ear assessments, the rate of ear problems, and education outcomes over four years.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Training and employment of community members as Ear and Hearing Clinical and Education Support Officers to assist with ear health diagnosis and management
What this could lead to
If successful, this could reduce ear infections and hearing loss in Aboriginal children, improving their learning and long-term outcomes.
What could go wrong
The trial is small and early, and results may not apply to all communities. Success depends on community engagement and integration into existing services.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

18 people

The number who actually took part.

Started

Feb 2019

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

1 week to 16 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Aboriginal or Torres Strait Islander, resident in participating community (cluster) Exclusion Criteria: none

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Conductive hearing loss are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

conductive hearing loss disorder Hearing Loss, Conductive otitis media

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Conductive hearing loss Otitis media

Contacts and locations

Locations

  • Ali Curung

    Ali Curung, Northern Territory, Australia

  • Ampilatwatja

    Ampilatwatja, Northern Territory, Australia

  • Darwin

    Darwin, Northern Territory, 0800, Australia

  • Galiwin'ku

    Galiwin'ku, Northern Territory, Australia

  • Gunbalanya

    Gunbalanya, Northern Territory, Australia

  • Julanimawu (Nguiu) Community Health centre

    Wurrumiyanga, Northern Territory, 0822, Australia

  • Kalkarindji Primary Health Centre

    Kalkarindji, Northern Territory, 0852, Australia

  • Lajamanu Primary Health Centre

    Lajamanu, Northern Territory, Australia

  • Mala'la Health Service

    Maningrida, Northern Territory, 0820, Australia

  • Milikapiti Community Health Centre

    Milikapiti, Northern Territory, Australia

  • Milingimbi Health Clinic

    Milingimbi, Northern Territory, 0822, Australia

  • Minjilang Community Health Centre

    Minjilang, Northern Territory, Australia

  • Nauiyu

    Nauiyu, Northern Territory, Australia

  • Palumpa Community Health Centre

    Palumpa, Northern Territory, 0822, Australia

  • Pirlangimpi Health Clinic

    Pirlangimpi, Northern Territory, 0822, Australia

  • Ti Tree Community Health Centre

    Ti Tree, Northern Territory, 0872, Australia

  • Wadeye Community Health Centre

    Wadeye, Northern Territory, 0822, Australia

  • Warruwi Community Health Centre

    Warruwi, Northern Territory, 0822, Australia

  • Wurli Wurlinjang Health Service

    Katherine, Northern Territory, 0850, Australia

  • Yirrkala Clinic

    Yirrkala, Northern Territory, 0880, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.